Background and Objectives: Melanoma mutational burden is high and approximately 50% have oncogenic mutations inBRAF. We sought to evaluate age‐related mutational differences in melanoma.Methods: We analyzed melanoma samples in the Genomics Evidence Neoplasia Information Exchange database. Targetable mutations were identified using the Precision Oncology Knowledge Base (OncoKB).Results: We found 1194 patients with a common set of 30 genes. The top mutated genes in patients <40 years old (y/o) (n = 98) wereBRAF(59%),TP53(31%),NRAS(17%), andPTEN(14%); in 40–59 y/o (n = 354) wereBRAF(51%),NRAS(30%),TP53(26%), andAPC(13%); and in ≥60 y/o (n = 742) wereBRAF(38%),NRAS(33%),TP53(26%), andKDR(19%).BRAFmutations were almost mutually exclusive fromNRASmutations in <40 y/o (58/59). Mutational burden increased with age, with means of 2.39, 2.92, and 3.67 mutations per sample in patients <40, 40–59, and ≥60 y/o, respectively (p < 0.0001). There were 10 targetable mutations meeting OncoKB criteria for melanoma:BRAF(level 1),RET(level 1),KIT(level 2),NRAS(level 3A),TP53(level 3A), andFGFR2,MET,PTEN,PIK3CA, andKRAS(level 4).Conclusions: Mutations in melanoma have age‐related differences and demonstrates potential targetable mutations for personalized therapies.